Are you Dr. Perlman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 35 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
618 Mirada Ave
Stanford, CA 94305Phone+1 650-270-6831Fax+1 650-322-9710
Summary
- Dr. Andrew Perlman, MD is a board certified internist in Stanford, California. He is currently licensed to practice medicine in California and New York.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1975 - 1979
New York University School of MedicineClass of 1975
Certifications & Licensure
NY State Medical License 1979 - Present
CA State Medical License 1976 - 2025- American Board of Internal Medicine Internal Medicine
Clinical Trials
- A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN) Start of enrollment: 2014 Jul 09
Publications & Presentations
PubMed
- 77 citationsSerlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trial.Sonja Ständer, Paul Kwon, Joe Hirman, Andrew J. Perlman, Elke Weisshaar
Journal of the American Academy of Dermatology. 2019-05-01 - 80 citationsSerlopitant for the treatment of chronic pruritus: Results of a randomized, multicenter, placebo-controlled phase 2 clinical trialGil Yosipovitch, Sonja Ständer, Matthew B. Kerby, James W. Larrick, Andrew J. Perlman
Journal of the American Academy of Dermatology. 2018-05-01 - Development of more potent atrial natriuretic factor (ANF) analogsDong Li Song, Berit Madsen, Jaw-Kang Chang, Andrew J. Perlman
European Journal of Pharmacology. 1989-01-24
